Cargando…

CAMEL NANOBODIES NEUTRALIZE SARS-COV-2 VARIANTS

BACKGROUND AND SIGNIFICANCE: With the emergence of SARS-CoV-2 variants during the global pandemic from 2020 to 2023, there is need for broadly neutralizing antibodies. Due to their small size and unique conformations, nanobodies can recognize protein cavities that are not accessible to conventional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Jessica, Kwon, Hyung Joon, Cachau, Raul, Butay, Kevin John, Duan, Zhijian, Li, Dan, Ren, Hua, Hsieh, Chao-Ming, Dandey, Venkata P, Borgnia, Mario J, Xie, Hang, Ho, Mitchell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370441/ http://dx.doi.org/10.1093/abt/tbad014.001

Ejemplares similares

Camel nanobodies broadly neutralize SARS-CoV-2 variants
por: Hong, Jessica, et al.
Publicado: (2021)

Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants
por: Hong, Jessica, et al.
Publicado: (2022)

Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2
por: Chouchane, Lotfi, et al.
Publicado: (2021)

Nanobodies that Neutralize HIV
por: Weiss, Robin A., et al.
Publicado: (2019)

Characterization of rabbit polyclonal antibody against camel recombinant nanobodies
por: Khalaf, Houssam-Eddin, et al.
Publicado: (2022)

Camels’ biological fluids contained nanobodies: promising avenue in cancer therapy
por: Al-Numair, Nouf S., et al.
Publicado: (2022)

Structural basis of nanobodies neutralizing SARS-CoV-2 variants
por: Shi, Zhenzhong, et al.
Publicado: (2022)

CAMEL NANOBODY-BASED B7-H3 CAR-T CELLS WITH HIGH EFFICACY AGAINST SOLID TUMORS
por: Li, Dan, et al.
Publicado: (2023)

Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies
por: Dhaouadi, Sayda, et al.
Publicado: (2021)

Correction: Camels’ biological fluids contained nanobodies: promising avenue in cancer therapy
por: Al‑Numair, Nouf S., et al.
Publicado: (2023)

An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
por: Chi, Xiaojing, et al.
Publicado: (2022)

Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19)
por: Bessalah, Salma, et al.
Publicado: (2021)

Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours
por: Li, Dan, et al.
Publicado: (2023)

Neutralization of Human Interleukin 23 by Multivalent Nanobodies Explained by the Structure of Cytokine–Nanobody Complex
por: Desmyter, Aline, et al.
Publicado: (2017)

A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
por: Weinstein, Jules B., et al.
Publicado: (2022)

Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants
por: Xu, Jianliang, et al.
Publicado: (2021)

Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralization
por: Yang, Jing, et al.
Publicado: (2023)

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes
por: Sun, Dapeng, et al.
Publicado: (2021)

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
por: Sun, Dapeng, et al.
Publicado: (2021)

A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike
por: Fu, Ying, et al.
Publicado: (2022)

Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants
por: Li, Tingting, et al.
Publicado: (2022)

Accelerating PERx reaction enables covalent nanobodies for potent neutralization of SARS-CoV-2 and variants
por: Yu, Bingchen, et al.
Publicado: (2022)

A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
por: Chen, Xun, et al.
Publicado: (2021)

Prospects of Neutralizing Nanobodies Against SARS-CoV-2
por: Chen, Fangfang, et al.
Publicado: (2021)

MERS Coronavirus Neutralizing Antibodies in Camels, Eastern Africa, 1983–1997
por: Müller, Marcel A., et al.
Publicado: (2014)

Antibody–nanobody combination increases their neutralizing activity against SARS-CoV-2 and nanobody H11-H4 is effective against Alpha, Kappa and Delta variants
por: Nguyen, Hung, et al.
Publicado: (2022)

Isolation of an escape-resistant SARS-CoV-2 neutralizing nanobody from a novel synthetic nanobody library
por: Dormeshkin, Dmitri, et al.
Publicado: (2022)

Flipped Over U: Structural Basis for dsRNA Cleavage by the SARS-CoV-2 Endoribonuclease
por: Frazier, Meredith N., et al.
Publicado: (2022)

Molecular basis of polyspecific drug binding and transport by OCT1 and OCT2
por: Suo, Yang, et al.
Publicado: (2023)

Bioscreening and expression of a camel anti-CTGF VHH nanobody and its renaturation by a novel dialysis–dilution method
por: Xue, Xiulei, et al.
Publicado: (2016)

Development of Neutralizing Nanobodies to the Hemagglutinin Stem Domain of Influenza A Viruses
por: Voronina, D. V., et al.
Publicado: (2021)

Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

Development of Thermally Stable Nanobodies for Detection and Neutralization of Staphylococcal Enterotoxin B
por: Hughes, Anna C., et al.
Publicado: (2023)

A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants
por: Modhiran, Naphak, et al.
Publicado: (2023)

A Naïve Phage Display Library-Derived Nanobody Neutralizes SARS-CoV-2 and Three Variants of Concern
por: Wu, Dandan, et al.
Publicado: (2023)

Protective Bleaching of Camel Hair in a Neutral Ethanol–Water System
por: Xia, Liangjun, et al.
Publicado: (2018)

Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization
por: Koromyslova, Anna D., et al.
Publicado: (2017)

An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
por: Hanke, Leo, et al.
Publicado: (2020)

Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization
por: Zebardast, Arghavan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6tb8ac658dnc703pcklutvajoa